ALLMedicine™ Diabetic Foot Infections Center
Research & Reviews 254 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780019
Seminars in Vascular Surgery; Pride L, Kabeil M et. al.
Mar 24th, 2023 - The COVID-19 pandemic has profoundly affected health care delivery. In addition to the significant morbidity and mortality associated with acute illness from COVID-19, the indirect impact has been far-reaching, including substantial disruptions in...
https://doi.org/10.2106/JBJS.22.00718
The Journal of Bone and Joint Surgery. American Volume; Ron I, Kyin C et. al.
Mar 22nd, 2023 - Transmetatarsal amputation (TMA) is a well-recognized limb-salvage procedure, often indicated for the treatment of diabetic foot infections. Currently, there is no widespread agreement in the literature with regard to the factors associated with f...
https://doi.org/10.1053/j.jfas.2022.06.006
The Journal of Foot and Ankle Surgery : Official Publicat... Coye TL, Foote C et. al.
Mar 16th, 2023 - The primary objective of this study was to assess the negative predictive value of methicillin-resistant Staphylococcus aureus (MRSA) nasal swabs in MRSA diabetic foot infections. MEDLINE and Cochrane Library were searched from inception to May 1,...
https://doi.org/10.1111/wrr.13074
Wound Repair and Regeneration : Official Publication of T... Ji X, Jin P et. al.
Mar 8th, 2023 - Diabetic foot ulcers (DFUs) are among the most common complications in patients with diabetes and a leading cause of lower extremity amputation. DFUs are exacerbated by prolonged bacterial infection; therefore, there is an urgent need for effectiv...
https://clinicaltrials.gov/ct2/show/NCT05753215
Mar 3rd, 2023 - The study design is a randomized, open-label, clinical trial of omadacycline vs Standard of Care (SOC) antibiotics for bone and join infection (BJI) treatment. Study participants will have their BJI regimen chosen by their treating physicians, (ty...
Guidelines 1 results
https://doi.org/10.1093/cid/cis346
Clinical Infectious Diseases : an Official Publication Of... Lipsky BA, Berendt AR et. al.
May 24th, 2012 - Foot infections are a common and serious problem in persons with diabetes. Diabetic foot infections (DFIs) typically begin in a wound, most often a neuropathic ulceration. While all wounds are colonized with microorganisms, the presence of infecti...
Drugs 89 results see all →
Clinicaltrials.gov 28 results
https://clinicaltrials.gov/ct2/show/NCT05753215
Mar 3rd, 2023 - The study design is a randomized, open-label, clinical trial of omadacycline vs Standard of Care (SOC) antibiotics for bone and join infection (BJI) treatment. Study participants will have their BJI regimen chosen by their treating physicians, (ty...
https://clinicaltrials.gov/ct2/show/NCT04081792
Mar 1st, 2023 - Trial 1: At enrollment (Day 1), the investigator will prescribe empiric antibiotic treatment based on instructions provided in the protocol and determine the most appropriate route of administration (oral or IV) according to the patient's conditio...
https://clinicaltrials.gov/ct2/show/NCT05502380
Feb 28th, 2023 - The perioperative antibiotic prophylaxis is evidence-based for the majority of orthopedic surgeries. While the debate of its duration and timing (single-dose versus triple-dose; before or after the intraoperative microbiological sampling) may cont...
https://clinicaltrials.gov/ct2/show/NCT05499481
Feb 28th, 2023 - The optimal duration of postoperative, systemic antibiotic therapy for implant-related orthopedic infections, with or without implant removal, is unknown. Retrospective studies suggest that a maximum duration of 6 weeks is not inferior to longer a...
https://clinicaltrials.gov/ct2/show/NCT04714411
Feb 17th, 2023 - This is a year-long study with planned enrollment of 57 patients (in addition to 114 historical control patients) evaluating the use of omadacycline for treatment of diabetic foot infections (DFI). Omadacycline (Nuzyra®) is a FDA approved antibiot...
News 38 results
https://www.medscape.com/viewarticle/925981
Mar 2nd, 2020 - At its February meeting, the European Medicines Agency's (EMA's) Committee for Medicinal Products for Human Use (CHMP) recommended two antibacterial agents: cefiderocol and a generic version of tigecycline. Cefiderocol (Fetcroja, Shionogi BV) is f...
https://www.mdedge.com/familymedicine/article/113703/infectious-diseases/many-patients-diabetic-foot-infections-get
Dermatology News; Lucas Franki
Sep 13th, 2016 - Many patients with diabetic foot infections receive methicillin-resistant Staphylococcus aureus antibiotics unnecessarily, according to Kelly Reveles, PharmD, and her associates. Among the 318 patients with diabetic foot infections (DFIs) in the s.
https://www.mdedge.com/diabeteshub/article/113703/infectious-diseases/many-patients-diabetic-foot-infections-get
Lucas Franki
Sep 13th, 2016 - Many patients with diabetic foot infections receive methicillin-resistant Staphylococcus aureus antibiotics unnecessarily, according to Kelly Reveles, PharmD, and her associates. Among the 318 patients with diabetic foot infections (DFIs) in the s.
https://www.mdedge.com/infectiousdisease/article/113703/infectious-diseases/many-patients-diabetic-foot-infections-get
Lucas Franki
Sep 13th, 2016 - Many patients with diabetic foot infections receive methicillin-resistant Staphylococcus aureus antibiotics unnecessarily, according to Kelly Reveles, PharmD, and her associates. Among the 318 patients with diabetic foot infections (DFIs) in the s.
https://www.mdedge.com/dermatology/article/105627/aesthetic-dermatology/royal-jelly
Leslie S. Baumann, MD
Jan 7th, 2016 - Used for centuries by humans for its health-promoting qualities, royal jelly is a yellowish, viscous secretion from the hypopharyngeal and mandibular glands of worker bees that nourishes bee larvae of all kinds (i. e.